BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 23963515)

  • 1. Technologies for label-free separation of circulating tumor cells: from historical foundations to recent developments.
    Jin C; McFaul SM; Duffy SP; Deng X; Tavassoli P; Black PC; Ma H
    Lab Chip; 2014 Jan; 14(1):32-44. PubMed ID: 23963515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Circulating tumor cells: liquid biopsy].
    Alix-Panabières C; Pierga JY
    Bull Cancer; 2014 Jan; 101(1):17-23. PubMed ID: 24445939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating tumor cells: a multifunctional biomarker.
    Yap TA; Lorente D; Omlin A; Olmos D; de Bono JS
    Clin Cancer Res; 2014 May; 20(10):2553-68. PubMed ID: 24831278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances and prospects in the isolation by size of epithelial tumor cells (ISET) methodology.
    Ma YC; Wang L; Yu FL
    Technol Cancer Res Treat; 2013 Aug; 12(4):295-309. PubMed ID: 23448577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Looking back, to the future of circulating tumor cells.
    Friedlander TW; Premasekharan G; Paris PL
    Pharmacol Ther; 2014 Jun; 142(3):271-80. PubMed ID: 24362084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Technologies for detection of circulating tumor cells: facts and vision.
    Alix-Panabières C; Pantel K
    Lab Chip; 2014 Jan; 14(1):57-62. PubMed ID: 24145967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances and critical concerns with the microfluidic enrichments of circulating tumor cells.
    Hyun KA; Jung HI
    Lab Chip; 2014 Jan; 14(1):45-56. PubMed ID: 23982141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advanced technologies for studying circulating tumor cells at the protein level.
    Chan CM; Au TC; Chan AT; Ma BB; Tsui NB; Ng SS; Hui EP; Chan LW; Ho WS; Yung BY; Wong SC
    Expert Rev Proteomics; 2013 Dec; 10(6):579-89. PubMed ID: 24206230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection and isolation of circulating tumor cells: principles and methods.
    Esmaeilsabzali H; Beischlag TV; Cox ME; Parameswaran AM; Park EJ
    Biotechnol Adv; 2013 Nov; 31(7):1063-84. PubMed ID: 23999357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Size-based enrichment technologies for CTC detection and characterization.
    Williams A; Balic M; Datar R; Cote R
    Recent Results Cancer Res; 2012; 195():87-95. PubMed ID: 22527497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overview of current standpoints in profiling of circulating tumor cells.
    Kim K; Lee KH; Lee J; Choi J
    Arch Pharm Res; 2014 Jan; 37(1):88-95. PubMed ID: 24214218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microfluidics and circulating tumor cells.
    Dong Y; Skelley AM; Merdek KD; Sprott KM; Jiang C; Pierceall WE; Lin J; Stocum M; Carney WP; Smirnov DA
    J Mol Diagn; 2013 Mar; 15(2):149-57. PubMed ID: 23266318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Towards a personalized breast cancer treatment approach guided by circulating tumor cell (CTC) characteristics.
    Onstenk W; Gratama JW; Foekens JA; Sleijfer S
    Cancer Treat Rev; 2013 Nov; 39(7):691-700. PubMed ID: 23683721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Size-based separation methods of circulating tumor cells.
    Hao SJ; Wan Y; Xia YQ; Zou X; Zheng SY
    Adv Drug Deliv Rev; 2018 Feb; 125():3-20. PubMed ID: 29326054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microfluidic isolation of platelet-covered circulating tumor cells.
    Jiang X; Wong KHK; Khankhel AH; Zeinali M; Reategui E; Phillips MJ; Luo X; Aceto N; Fachin F; Hoang AN; Kim W; Jensen AE; Sequist LV; Maheswaran S; Haber DA; Stott SL; Toner M
    Lab Chip; 2017 Oct; 17(20):3498-3503. PubMed ID: 28932842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benchtop technologies for circulating tumor cells separation based on biophysical properties.
    Low WS; Wan Abas WA
    Biomed Res Int; 2015; 2015():239362. PubMed ID: 25977918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating tumour cells in clinical practice: Methods of detection and possible characterization.
    Alunni-Fabbroni M; Sandri MT
    Methods; 2010 Apr; 50(4):289-97. PubMed ID: 20116432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation of rare circulating tumor cells in cancer patients: technical aspects and clinical implications.
    Danova M; Torchio M; Mazzini G
    Expert Rev Mol Diagn; 2011 Jun; 11(5):473-85. PubMed ID: 21707456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating tumor cells: evolving evidence and future challenges.
    Dotan E; Cohen SJ; Alpaugh KR; Meropol NJ
    Oncologist; 2009 Nov; 14(11):1070-82. PubMed ID: 19897536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a molecular multimarker assay for the analysis of circulating tumor cells in adenocarcinoma patients.
    de Albuquerque A; Kubisch I; Ernst D; Breier G; Stamminger G; Fersis N; Stölzel U; Boese-Landgraf J; Eichler A; Kaul S
    Clin Lab; 2012; 58(5-6):373-84. PubMed ID: 22783565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.